Clincosm LogoSign in Get a demo

Malignancy

Showing 1 - 25 of 72
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cardiovascular Toxicity: Comprehensive Myocardial and Vascular

Recruiting
  • Cardiovascular Diseases
  • +7 more
  • Cardiovascular magnetic resonance with stress perfusion
  • +4 more
  • London, United Kingdom
    St Bartholomews Hospital
Sep 15, 2023

Hydronephrosis; Obstruction, Ureter, Renal Failure, Malignancy Trial in Petah Tikva, Ramat Gan (ureteral stent\s insertion)

Not yet recruiting
  • Hydronephrosis; Obstruction, Ureter
  • +4 more
  • ureteral stent\s insertion
  • Petah Tikva, Israel
  • +1 more
Aug 8, 2023

Cancer, Malignancy, Malignant Tumor Trial (Digital Intervention, Community Outreach)

Not yet recruiting
  • Cancer
  • +2 more
  • Digital Intervention
  • Community Outreach
  • (no location specified)
May 23, 2023

Prostate Disease, Malignancy, Benign Prostatic Hyperplasia Trial in Boston (Self-Administered Nitrous Oxide, Oxygen)

Completed
  • Prostate Disease
  • +6 more
  • Self-Administered Nitrous Oxide
  • Oxygen
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Mar 25, 2023

Solid Tumor, Haematological Malignancy, Malignancy Trial in United Kingdom (Entrectinib)

Recruiting
  • Solid Tumor
  • +10 more
  • Belfast, United Kingdom
  • +25 more
Mar 14, 2023

Malignancy, Malignant Tumor, Lymphoproliferative Disorders Trial in United Kingdom (Atezolizumab)

Not yet recruiting
  • Malignancy
  • +8 more
  • Belfast, United Kingdom
  • +25 more
Mar 14, 2023

Malignancy Trial in Beijing (Al18F-PSMA-BCH PET/CT)

Recruiting
  • Malignancy
  • Al18F-PSMA-BCH PET/CT
  • Beijing, Chaoyang, China
    National Cancer Center/Cancer Hospital,Chinese Academy of Medica
Mar 7, 2023

Abdominal Cancer, Malignancy Trial in Pittsburgh (Lipopolysaccharide)

Recruiting
  • Abdominal Cancer
  • Malignancy
  • Lipopolysaccharide
  • Pittsburgh, Pennsylvania
  • +1 more
Feb 28, 2023

Malignancy Trial in Beijing (Al18F-NOTA-FAPI)

Recruiting
  • Malignancy
  • Beijing, Chao Yang, China
    National Cancer Center/Cancer Hospital,Chinese Academy of Medica
Feb 19, 2023

Malignancy, Metastasis, Hemoptysis Trial in Saint Louis (Volumetric MR imaging, Radiation therapy)

Completed
Has Results
  • Malignancy
  • +6 more
  • Volumetric MR imaging
  • Radiation therapy
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 4, 2023

GVHD, Malignancy Trial in Canada, United States (Abatacept, )

Active, not recruiting
Has Results
  • Graft vs Host Disease
  • Malignancy
  • Los Angeles, California
  • +13 more
Jan 9, 2023

Cancer, Urinary Obstruction, Malignancy Trial in Chicago (Ureteral Stent, Percutaneous Nephrostomy Tube Placement)

Not yet recruiting
  • Cancer
  • +5 more
  • Ureteral Stent
  • Percutaneous Nephrostomy Tube Placement
  • Chicago, Illinois
    The University of Chicago
Nov 28, 2022

Cancer, End Stage Cancer, Malignancy Trial in Baltimore (Community Health Worker (CHW) based palliative care)

Enrolling by invitation
  • Cancer
  • +3 more
  • Community Health Worker (CHW) based palliative care
  • Baltimore, Maryland
    Johns Hopkins University School of Medicine
Nov 8, 2022

Research Data and Samples From Patients Who Experience

Recruiting
  • Malignancy
  • Biospecimen Collection
  • Medical Chart Review
  • Anchorage, Alaska
  • +518 more
Sep 25, 2022

Lymphoproliferative Disorder, HHV-8, Malignancy Trial run by the National Cancer Institute (NCI) (Etoposide, Interferon-alpha,

Active, not recruiting
  • Lymphoproliferative Disorder
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Information Needs Around Parenteral nUTrition in Cancer

Completed
  • Cancer
  • +6 more
  • Non-interventional study
  • London, United Kingdom
  • +3 more
Jul 14, 2022

Cardiovascular Disease and Cancer in Korean Population: A

Not yet recruiting
  • Cardiovascular Diseases
  • +2 more
    • Ulsan, Korea, Republic of
      Ulsan University Hospital
    May 21, 2022

    Covid19, Cancer, Malignancy Trial in Tucson (SARS-COV2 Pfizer Vaccine)

    Completed
    • Covid19
    • +3 more
    • SARS-COV2 Pfizer Vaccine
    • Tucson, Arizona
      University of Arizona
    May 19, 2022

    Cancer, Malignancy, Refractory Cancer Trial in Singapore (Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted ?d T

    Not yet recruiting
    • Cancer
    • +3 more
    • Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells (CTM-N2D)
    • Singapore, Singapore
      National University Hospital
    Mar 20, 2022

    Cancer, Tumors, Tumor Trial in Worldwide (BMS-986226, Nivolumab, Ipilimumab)

    Completed
    • Cancer
    • +3 more
    • Boston, Massachusetts
    • +12 more
    Mar 11, 2022

    Solid Tumor, Carcinoma, Malignancy Trial in Hong Kong (propofol, sevoflurane)

    Recruiting
    • Solid Tumor
    • +3 more
    • Hong Kong, Hong Kong
      Hong Kong Children's Hospital
    Mar 14, 2022

    Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

    Recruiting
    • Malignancy
    • +14 more
    • Scottsdale, Arizona
    • +17 more
    Mar 7, 2022

    Malignancy, Immune System Diseases, Autoimmune Diseases Trial in Chapel Hill (Biospecimen Collection, Medical Chart Review,

    Recruiting
    • Malignancy
    • +2 more
    • Biospecimen Collection
    • +2 more
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Feb 11, 2022

    Advanced or Metastatic Solid Tumors, Malignancy, Metastasis Trial in Kurralta Park (AK114)

    Not yet recruiting
    • Advanced or Metastatic Solid Tumors
    • +2 more
    • Kurralta Park, South Australia, Australia
      Ashford Cancer Centre
    Jan 7, 2022

    Malignancy Trial in Shenzhen (Decitabine combined with NK cell infusion)

    Recruiting
    • Malignancy
    • Decitabine combined with NK cell infusion
    • Shenzhen, Guangdong, China
      Shenzhen University General hospital
    Nov 22, 2021